Publications:112
Nelly Alia-Klein, PhD
About Me
On January 2, 2013, Dr. Alia-Klein was appointed Associate Professor of Psychiatry (primary) and Neuroscience (secondary) at the Icahn School of Medicine at Mount Sinai and co-chief of Neuropsychoimaging of Addiction and Related Conditions (NARC) research program.
Prior to joining Mt. Sinai, Dr. Alia-Klein was Medical Scientist at Brookhaven National Laboratory in New York where she developed a program of study on aggression. She received her PhD from Columbia University in New York City. Dr. Alia-Klein is Principal Investigator on NIMH R01 and co-investigator on several grants from NIDA. As co-chief of NARC, Dr. Alia-Klein works on gene-brain-behavior modeling to predict anger and reactive aggression in clinical diagnoses as Intermittent Explosive Disorder. One of her goals is to further develop understanding and treatment of anger attacks in psychiatric disorders. She published on the neurochemistry modulating these behaviors and the reactivity interplay of prefrontal and subcortical brain regions during provocation or other challenge. Her tools probe select genotypes and their effects on brain function through application of MRI and PET technology. Other topics of study such as sex differences are also of interest, in particular as they affect anger disorders.
In the News
Nova Science Now, PBS series on the neurobiology of violent behavior, title: Can Science Stop Crime? (Aired 10/17/2012)
http://www.pbs.org/wgbh/nova/tech/can-science-stop-crime.html
PBS special After Newtown
http://video.pbs.org/video/2320006234/
Prior to joining Mt. Sinai, Dr. Alia-Klein was Medical Scientist at Brookhaven National Laboratory in New York where she developed a program of study on aggression. She received her PhD from Columbia University in New York City. Dr. Alia-Klein is Principal Investigator on NIMH R01 and co-investigator on several grants from NIDA. As co-chief of NARC, Dr. Alia-Klein works on gene-brain-behavior modeling to predict anger and reactive aggression in clinical diagnoses as Intermittent Explosive Disorder. One of her goals is to further develop understanding and treatment of anger attacks in psychiatric disorders. She published on the neurochemistry modulating these behaviors and the reactivity interplay of prefrontal and subcortical brain regions during provocation or other challenge. Her tools probe select genotypes and their effects on brain function through application of MRI and PET technology. Other topics of study such as sex differences are also of interest, in particular as they affect anger disorders.
In the News
Nova Science Now, PBS series on the neurobiology of violent behavior, title: Can Science Stop Crime? (Aired 10/17/2012)
http://www.pbs.org/wgbh/nova/tech/can-science-stop-crime.html
PBS special After Newtown
http://video.pbs.org/video/2320006234/
Language
English
Position
PROFESSOR | Psychiatry, PROFESSOR | Neuroscience
Research Topics
Addiction, Brain Imaging
Multi-Disciplinary Training Areas
Neuroscience [NEU]
Publications
Selected Publications
- Sex and Hormonal Effects on Drug Cue Reactivity and Its Regulation in Human Addiction. Yuefeng Huang, Eduardo R. Butelman, Ahmet O. Ceceli, Greg Kronberg, Sarah G. King, Natalie E. McClain, Yui Ying Wong, Maggie Boros, K. Rachel Drury, Rajita Sinha, Nelly Alia-Klein, Rita Z. Goldstein. Biological Psychiatry
- Moving Beyond Self-Report in Characterizing Drug Addiction: Using Drug-Biased Behavior to Predict Treatment Completion and Dropout in Heroin-Primary, Medication-Maintained Opioid Use Disorder. Natalie McClain, Ahmet O. Ceceli, Kathryn Drury, Greg Kronberg, Eric L. Garland, Nelly Alia-Klein, Rita Z. Goldstein. Biological Psychiatry Global Open Science
- Dynamic Alterations in the Blood Transcriptome Characterize Drug Use Behavior and Co-Morbidities in Cocaine Use Disorder: A Preliminary Study. Chinwe Nwaneshiudu, Kiran Girdhar, Steven P Kleopoulos, Zhiping Shao, John F Fullard, Eduardo R Butelman, Muhammad A Parvaz, Rita Z Goldstein, Nelly Alia-Klein, Panos Roussos. European Journal of Neuroscience
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Alia-Klein has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.